Infectious Disease News Current Issue

The following articles appeared in the print edition of Infectious Disease News.

Table of Contents

• Rediscovering phages: ‘We finally have the tools to harness them’ Caitlyn Stulpin
• 1.2 million initiated DAA treatment for HCV between 2014 and 2020 Caitlyn Stulpin
• Antimicrobial resistance to clinically relevant antibiotics for N. meningitidis is rare Caitlyn Stulpin
• Average daily COVID-19 deaths higher on weekends than weekdays, global study finds Ken Downey Jr.
• Cats and dogs may pass antibiotic-resistant bacteria to their owners Caitlyn Stulpin
• CEPI’s moon shot: Developing pandemic vaccines in 100 days Caitlyn Stulpin
• Common pediatric infections returned last winter, study finds Rose Weldon
• COVID-19 vaccine hesitancy in autism caregivers decreased over time Rose Weldon
• Dexamethasone at discharge for COVID-19 does not reduce readmission, mortality Ken Downey Jr.
• Duration of symptoms shorter with omicron, app-based data show Caitlyn Stulpin
• Europe needs measles vaccination push, researchers warn Gerard Gallagher
• Fully vaccinated HCW tests positive for delta and omicron just 20 days apart Ken Downey Jr.
• Higher dose primaquine prevents relapse of P. vivax malaria, study finds Rose Weldon
• Ivermectin fails to lower incidence of hospitalization in large COVID-19 study Caitlyn Stulpin
• Less than half of people with latent TB in the US initiate therapy Caitlyn Stulpin
• Longer intervals between COVID-19 vaccine doses produce higher antibody levels Ken Downey Jr.
• Mycobacterial cultures not necessary for most periprosthetic joint infections Caitlyn Stulpin
• US data show ‘concerning decline’ in routine pediatric vaccinations Rose Weldon
• Older adults with COVID-19 have significantly increased risk for herpes zoster Caitlyn Stulpin
• Omicron more infectious, less severe than delta for young children Rose Weldon
• Only one-fifth of sexually active teens report STI testing Rose Weldon
• Oral tebipenem pivoxil hydrobromide shows promise for complicated UTI Caitlyn Stulpin
• Patients with HBV more likely to receive guideline-adherent care if they also have HIV Caitlyn Stulpin
• Pfizer begins pediatric trial of COVID-19 antiviral Rose Weldon
• Pfizer, BioNTech seek FDA authorization of COVID-19 booster for children Rose Weldon
• Prior cultures predict antibiotic susceptibility for patients with recurrent UTIs Caitlyn Stulpin
• Real-time genomic surveillance quickly detects hospital outbreaks Gerard Gallagher; Caitlyn Stulpin
• Rise in congenital syphilis a result of multiple factors, researchers find Caitlyn Stulpin
• Risk for death around four times higher from COVID-19 than flu, study finds Ken Downey Jr.
• STDs continue to surge during pandemic, CDC says Gerard Gallagher; Caitlyn Stulpin
• Stewardship recommendations less likely to be followed when made by a woman, study finds Caitlyn Stulpin
• Study finds easier, less toxic regimen for HIV-associated cryptococcal meningitis Gerard Gallagher
• Study finds racial, ethnic disparities in inappropriate antibiotic prescribing Ken Downey Jr.
• Surfaces near patients with C. auris commonly re-contaminated within hours of cleaning Caitlyn Stulpin
• These steps may identify patients eligible for shorter DAA therapy Caitlyn Stulpin
• US study finds some increase in resistant infections during pandemic Ken Downey Jr.
• Workplace a ‘major driver’ of COVID-19 among health care personnel Caitlyn Stulpin
• What bacterium is at the top of your list of targets for phages?
• WHO recommends Paxlovid for patients with non-severe COVID-19 Maria Marabito
• Ukrainian-American physicians are organizing war relief efforts — here’s what they need Maria Marabito
• Hooked on ID with Kelly M. Percival, PharmD, BCPS AQ-ID
• COVID-19 led to unprecedented decline in global life expectancy Maria Marabito
• Vertical transmission of COVID-19 rare, meta-analysis shows Kalie VanDewater
• Molnupiravir eliminates viral load, improves symptoms in patients with COVID-19 Maria Marabito
• Scheduling, workflow initiative doubles visits for HIV PrEP Maria Marabito
• Linezolid dosing as part of three-drug regimen for drug-resistant TB Kelly M. Percival, PharmD, BCPS, BCIDP